R/C TIOTROPIN 3D:Uses, Dosage, Benefits,Side Effects, Price, Composition and More

May 11, 2024

R/C TIOTROPIN 3D

Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg)

R/C TIOTROPIN 3D combination therapy of Ciclesonide (400mcg), Formoterol (12mcg), and Tiotropium (18mcg) is a medication regimen commonly prescribed for the management of chronic obstructive pulmonary disease (COPD) and asthma. This article aims to provide comprehensive insights into the uses, dosage recommendations, and precautions associated with this triple therapy.

Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg):

Ciclesonide (400mcg), Formoterol (12mcg), and Tiotropium (18mcg) combination therapy consists of an inhaled corticosteroid (ICS), a long-acting beta agonist (LABA), and a long-acting muscarinic antagonist (LAMA), respectively. Here's an in-depth overview of this medication:

Uses:

  • COPD Management: Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg) combination therapy is indicated for the maintenance treatment of COPD to improve symptoms and reduce exacerbations.
  • Asthma Control: It may also be prescribed as a maintenance treatment for asthma in patients who require additional bronchodilation and anti-inflammatory therapy.

Benefits:

  • Bronchodilation: The combination of Formoterol and Tiotropium provides dual bronchodilator effects, leading to improved airflow and symptom relief in COPD and asthma.
  • Anti-inflammatory Action: Ciclesonide, as an ICS, helps reduce airway inflammation and prevents asthma exacerbations in patients with concomitant asthma.
  • Improved Lung Function: The combined action of these medications results in improved lung function and better disease control in individuals with COPD or asthma.

Dosage:

  • The recommended dosage of Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg) combination therapy depends on the specific inhaler device used and individual patient characteristics.
  • Patients should be instructed on proper inhalation technique and device use by their healthcare provider or pharmacist.

Precautions:

  • Before initiating Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg) combination therapy, inform your healthcare provider about any allergies or medical conditions you have, including heart disease, hypertension, or diabetes.
  • Regular monitoring of lung function, symptoms, and potential adverse effects is essential to optimize treatment outcomes and ensure patient safety.

Conclusion:

Ciclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg) combination therapy offers a comprehensive approach to managing COPD and asthma by combining the benefits of an ICS, LABA, and LAMA. By understanding its uses, dosage, and precautions, patients can achieve improved symptom control and quality of life while minimizing risks. However, it's crucial to use this medication regimen under the guidance of a healthcare professional.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH